Citius Pharmaceuticals, Inc. License and Maintenance Revenue (Deprecated 2018-01-31)
Citius Pharmaceuticals, Inc. (CTXR) reported License and Maintenance Revenue (Deprecated 2018-01-31) of $75.00 thousand for the 6-month period ending 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndMaintenanceRevenue · last filed 2018-05-11
- Citius Pharmaceuticals, Inc. license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $45.00K, a 50.00% increase year-over-year.
- Citius Pharmaceuticals, Inc. license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $30.00K.
- Citius Pharmaceuticals, Inc. license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $30.00K.
- Citius Pharmaceuticals, Inc. license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $30.00K, a 0.00% change year-over-year.
| Period end | License and Maintenance Revenue (Deprecated 2018-01-31) 3 month | License and Maintenance Revenue (Deprecated 2018-01-31) 6 month | License and Maintenance Revenue (Deprecated 2018-01-31) 9 month | License and Maintenance Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $75.00K 10-Q · filed 2018-05-11 | ||
| 2017-12-31 | $30.00K 10-Q · filed 2018-02-14 | |||
| 2017-09-30 | $50.00K 10-Q · filed 2018-05-11 | |||
| 2017-06-30 | $30.00K 10-Q · filed 2017-08-14 | $60.00K derived: sum of 2 quarters · filed 2017-08-14 | ||
| 2017-03-31 | $30.00K 10-Q · filed 2017-05-15 | |||
| 2016-09-30 | $30.00K 10-K · filed 2017-12-13 | |||
| 2016-03-31 | $30.00K 10-Q · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |